Daniel completed his PhD at the University of Sydney before moving to postdoctoral studies at the Wellcome Trust Sanger Institute in Cambridge, UK, and then a faculty position at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard in Boston. He co-directed the Broad Institute’s Program in Medical and Population Genetics, as well as the Broad Center for Mendelian Genomics, which sequenced the exomes, genomes, and/or transcriptomes of over 10,000 individuals from families affected by severe Mendelian disease, resulting in over 3,000 new diagnoses for patients. He also led the Genome Aggregation Database (gnomAD) consortium, which produced the world’s largest catalogues of human genetic variation, now spanning DNA sequence data from over 800,000 people. Daniel returned to Australia in 2020 as the inaugural director of the newly formed Centre for Population Genomics.

With a robust and diverse background in operational leadership, Elise has served in key roles including Operations Director at Wintermute Biomedical and CX Manager, Oceania at Merit Medical. Prior to this, she was a founder and entrepreneur with a focus on professional services support and large-scale public event production. As Associate Director, she is integral in steering the development and execution of the Centre’s organisational strategy, nurturing its emerging culture, and ensuring the organisation’s long-term sustainability. She is currently completing an MBA at AGSM.

Cas previously led research teams at the Institute for Molecular Bioscience (University of Queensland) and at the Murdoch Children’s Research Institute, with a focus on understanding the genetic underpinning of rare and undiagnosed genetic disorders, and also served as head of computational biology at the Queensland Facility for Applied Bioinformatics, leading a team of bioinformaticians and IT professionals to deliver contract research and analysis to a diverse life science clientele. Cas holds a PhD in Genomics and Computational Biology from the University of Queensland. As Lead of the CPG’s Rare Disease team, Cas’s current work is focussed on the diagnosis of rare genetic diseases and on developing improved computational approaches to identify the cause of rare genetic diseases.

Chris leads the OurDNA team at the Centre for Population Genomics (CPG). With a research background and a PhD in Drosophila genetics from Monash University, Chris has over a decade of experience managing large-scale research programs across industry, academic, and not-for-profit settings.

As the lead of the OurDNA program, Chris oversees the community engagement, participant recruitment, and sample management sub-teams, ensuring the successful delivery of OurDNA's mission to drive genomic discovery and equitable genomic medicine in Australia.

Zuong has a diverse background in law, policy and advocacy. She holds a Bachelor of Laws and Arts from Bond University, and Applied Neuroscience MSc from King's College London. Prior to joining CPG, Zuong was admitted to the Supreme Court of Queensland and Victoria and practised as a technology and privacy lawyer. She then joined Victoria's Department of Health as a senior policy adviser to support critical state-wide COVID-19 response policy and Ministerial priorities. She subsequently led multicultural health policy at the Department where she advocated for and advised on budget initiatives and policy development to improve health outcomes for under-represented communities. As Equity and Advocacy Lead, Zuong develops and drives policy, advocacy and engagement strategies for CPG both externally and internally, as well as contributes to the management and growth of CPG.

Hannah has over twenty years’ experience as a scientist, educator and research manager. Prior to joining CPG, Hannah held a research and teaching academic position in Molecular Biology at the University of Sydney. More recently she worked as a research programme manager at the Genome Institute of Singapore. Hannah holds a Bachelor of Medical Science (Hons) from the University of Sydney and a DPhil in Genetics from the University of Oxford.

As Scientific Affairs Manager, Hannah plays a leadership role in supporting CPG’s research program, overseeing the development of grants and scientific manuscripts, trainee support, and philanthropic fund-raising.

Katie has a background in computational biology, obtaining her BCMS(Hons) degree in computer science from the University of Waikato, New Zealand and her PhD in statistical genetics from the University of Cambridge (based at the Wellcome Trust Sanger Institute).

Most recently she has spent several years in the drug discovery industry, including at Vertex Pharmaceuticals in Boston and the Novartis Institutes for Biomedical Research in Switzerland, where she was working to translate genomic insights into novel therapeutics.

Katie co-leads the Population Analysis team, leveraging large-scale genomic datasets to better understand human health and disease.

Jennifer found her way into health and medical research after training as an astrophysicist, obtaining her BA in Astronomy from Columbia University and her PhD in Physics from Vanderbilt University. She is passionate about using her skill set in health informatics and data science to make research more equitable and inclusive. Prior to CPG, she worked as Lead Data Scientist on the Generation Victoria (GenV) project, developing novel ways to turn longitudinal cohort data into scientific insights. As co-lead for the Population Analysis team, she enables the analysis of a range of genomic datasets from diverse populations.

Chethana is a Software Lead in the Development Team, specializing in software engineering and project management. With a strong foundation in computer science, she brings 18 years of expertise in Software development, DevOps, test automation, agile methodologies and cloud technologies. She believes in the power of technology to simplify life and is passionate about driving innovation while delivering impactful solutions.